Abstract
This chapter discusses excessive daytime sleepiness (EDS) related to primary sleep disorders other than obstructive sleep apnea syndrome (OSAS) and restless legs syndrome (RLS) and EDS secondary to other medical problems-the secondary hypersomnias.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Liu, X., M. Uchiyama, K. Kim, et al., Sleep loss and daytime sleepiness in the general adult population of Japan. Psychiatry Res, 2000;93(1):1–11.
Doi, Y. and M. Minowa, Gender differences in excessive daytime sleepiness among Japanese workers. Soc Sci Med, bd2003];56(4):883–894.
Lichstein, K.L., H.H. Durrence, B.W. Riedel, D.J. Taylor, and A.J. Bush, Epidemiology of Sleep. Mahwah, NJ: Lawrence Erlbaum Associates, 2004:238.
Johns, M. and B. Hocking, Daytime sleepiness and sleep habits of Australian workers. Sleep, 1997;20(10):844–849.
Baldwin, C.M., V.K. Kapur, C.J. Holberg, C. Rosen, and F.J. Nieto, Associations between gender and measures of daytime somnolence in the Sleep Heart Health Study. Sleep, 2004;27(2):305–311.
Liu, X., Z. Sun, M. Uchiyama, K. Shibui, K. Kim, and M. Okawa, Prevalence and correlates of sleep problems in Chinese schoolchildren. Sleep, 2000;23(8):1053–1062.
Doghramji, K., M.M. Mitler, R.B. Sangal, et al., A normative study of the maintenance of wakefulness test (MWT). Electroencephalogr Clin Neurophysiol, 1997;103(5):554–562.
Mitler, M.M., K. Doghramji, and C. Shapiro, The maintenance of wakefulness test: normative data by age. J Psychosom Res, 2000;49(5):363–365.
American Academy of Sleep Medicine. The International Classification of Sleep Disorders, revised. Diagnostic and Coding Manual. Chicago: American Academy of Sleep Medicine, 2001.
Billiard, M., C. Guilleminault, and W.C. Dement, A menstruation-linked periodic hypersomnia. Kleine-Levin syndrome or new clinical entity? Neurology, 1975;25(5):436–443.
Papy, J.J., B. Conte-Devolx, J. Sormani, R. Porto, and V. Guillame, [The periodic hypersomnia and megaphagia syndrome in a young female, correlated with menstrual cycle (author’ transl)]. Rev Electroencephalogr Neurophysiol Clin, 1982;12(1):54–61.
Sachs, C., H.E. Persson, and K. Hagenfeldt, Menstruation-related periodic hypersomnia: a case study with successful treatment. Neurology, 1982;32(12):1376–1379.
Bamford, C.R., Menstrual-associated sleep disorder: an unusual hypersomniac variant associated with both menstruation and amenorrhea with a possible link to prolactin and metoclopramide. Sleep, 1993;16(5):484–486.
Manber, R. and R.R. Bootzin, Sleep and the menstrual cycle. Health Psychol, 1997;16(3):209–214.
Lemire, I., [Review of Kleine-Levin syndrome: toward an integrated approach]. Can J Psychiatry, 1993;38(4):277–284.
Rosenow, F., P. Kotagal, B.H. Cohen, C. Green, and E. Wyllie, Multiple sleep latency test and polysomnography in diagnosing Kleine-Levin syndrome and periodic hypersomnia. J Clin Neurophysiol, 2000;17(5):519–522.
Rye, D.B., B. Dihenia, J.D. Weissman, C.M. Epstein, and D.L. Bliwise, Presentation of narcolepsy after 40. Neurology, 1998;50(2):459–465.
Wise, M.S., Childhood narcolepsy. Neurology, 1998;50(2 Suppl 1):S37–S42.
Black, J.E., S.N. Brooks, and S. Nishino, Narcolepsy and syndromes of primary excessive daytime somnolence. Semin Neurol, 2004;24(3):271–282.
Ellis, M.C., A.H. Hetisimer, D.A. Ruddy, et al., HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy. Immunogenetics, 1997;46(5):410–417.
Mignot, E., A. Kimura, A. Lattermann, et al., Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens, 1997;49(4):329–341.
Sakurai, T., A. Amemiya, M. Ishii, et al., Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 1998;92(4):573–585.
Kanbayashi, T., Y. Inoue, S. Chiba, et al., CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res, 2002;11(1):91–93.
Lin, L., J. Faraco, R. Li, et al., The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 1999;98(3):365–376.
Chemelli, R.M., J.T. Willie, C.M. Sinton, et al., Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell, 1999;98(4):437–451.
Thannickal, T.C., R.Y. Moore, R. Nienhuis, et al., Reduced number of hypocretin neurons in human narcolepsy. Neuron, 2000;27(3):469–474.
Nishino, S., B. Ripley, S. Overeem, G.J. Lammers, and E. Mignot, Hypocretin (orexin) deficiency in human narcolepsy. Lancet, 2000;355(9197):39–40.
Khatami, R., S. Maret, E. Werth, et al., Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway. Lancet, 2004;363(9416):1199–1200.
Ohayon, M.M., M. Caulet, P. Philip, C. Guilleminault, and R.G Priest, How sleep and mental disorders are related to complaints of daytime sleepiness. Arch Intern Med, 1997;157(22):2645–2652.
Thorpy, M.J., J.R. Schwartz, R. Kovacevic-Ristanovic, and R. Hayduk, Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies. Psychopharmacology (Berl), 2003;167(4):380–385.
Littner, M., S.F. Johnson, W.V. McCall, et al., Practice parameters for the treatment of narcolepsy: an update for 2000. Sleep, 2001;24(4):451–466.
Akaoka, H., B. Roussel, J.S. Lin, G. Chouvet, and M. Jouvet, Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity. Neurosci Lett, 1991;123(1):20–22.
Ferraro, L., T. Antonelli, W.T. O’Connor, S. Tanganelli, F.A. Rambert, and K. Fuxe, Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biol Psychiatry, 1997;42(12):1181–1183.
Engber, T.M., E.J. Koury, S.A. Dennis, M.S. Miller, C. Contreras, and R.V. Bhat, Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulnesspromoting agent modafinil. Neurosci Lett, 1998;241(2–3):95–98.
Lin, J.S., Y. Hou, and M. Jouvet, Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA, 1996;93(24):14128–1433.
Scammell, T.E., I.V. Estabrooke, M.T. McCarthy, et al., Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci, 2000;20(22):8620–8628.
U.S. Xyrem Multicenter Study Group, Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med, 2004;5(2):119–123.
Scrima, L., P.G. Hartman, F.H. Johnson Jr., E.E. Thomas, and F.C. Hiller, The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study. Sleep, 1990;13(6):479–490.
Billiard, M. and Y. Dauvilliers, Idiopathic hypersomnia. Sleep Med Rev, 2001;5(5):349–358.
Dauvilliers, Y., C.R. Baumann, B. Carlander, et al., CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry, 2003;74(12):1667–1673.
Bassetti, C., M. Gugger, M. Bischof, et al., The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep Med, 2003;4(1):7–12.
Bassetti, C. and M.S. Aldrich, Idiopathic hypersomnia. A series of 42 patients. Brain, 1997;120(Pt 8):1423–1435.
Billiard, M., Idiopathic hypersomnia. Neurol Clin, 1996;14(3):573–582.
Jameson, L.J. and A.P. Weetman, Disorders of the thyroid gland. In: Harrison’ Principles of Internal Medicine (D.L. Kasper, et al., eds.). Hightstown, NJ: McGraw-Hill, 2004:2104–2127.
Lin, C.C., K.W. Tsan, and P.J. Chen, The relationship between sleep apnea syndrome and hypothyroidism. Chest, 1992;102(6):1663–1667.
Miller, C.M. and A.M. Husain, Should women with obstructive sleep apnea syndrome be screened for hypothyroidism? Sleep Breath, 2003;7(4):185–188.
Skjodt, N.M., R. Atkar, and P.A. Easton, Screening for hypothyroidism in sleep apnea. Am J Respir Crit Care Med, 1999;160(2):732–735.
Khan, A.A., C.O. Gardner, C.A. Prescott, and K.S. Kendler, Gender differences in the symptoms of major depression in opposite-sex dizygotic twin pairs. Am J Psychiatry, 2002;159(8):1427–1429.
Sadock, B.J. and V.A. Sadock, Mood disorders. In: Kaplan and Sadock’ Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry (B.J. Sadock and V.A. Sadock, eds.). Philadelphia: Lippincott Williams & Wilkins, 2002:534–572.
Vgontzas, A.N., E.O., Bixler, A. Kales, C. Criley, and A. Vela-Bueno, Differences in nocturnal and daytime sleep between primary and psychiatric hypersomnia: diagnostic and treatment implications. Psychosom Med, 2000;62(2):220–226.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Attarian, H.P. (2006). Women and Excessive Daytime Sleepiness. In: Attarian, H.P. (eds) Sleep Disorders in Women. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59745-115-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-59745-115-4_12
Publisher Name: Humana Press
Print ISBN: 978-1-58829-592-7
Online ISBN: 978-1-59745-115-4
eBook Packages: MedicineMedicine (R0)